tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Chimeric Therapeutics Appoints New Director, Miles Prince
Company AnnouncementsChimeric Therapeutics Appoints New Director, Miles Prince
3d ago
CHM
Chimeric Therapeutics Announces Director’s Interest Change
PremiumCompany Announcements
Chimeric Therapeutics Announces Director’s Interest Change
4d ago
CHM
Chimeric Therapeutics Strengthens Board with Appointment of Renowned Haematologist
PremiumCompany Announcements
Chimeric Therapeutics Strengthens Board with Appointment of Renowned Haematologist
5d ago
CHM
Chimeric Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Chimeric Therapeutics Announces Cessation of Securities
9d ago
CHM
Chimeric Therapeutics Announces Extraordinary General Meeting
PremiumCompany Announcements
Chimeric Therapeutics Announces Extraordinary General Meeting
12d ago
CHM
Chimeric Therapeutics Reports Promising Results in CAR-T Cell Trial for GI Cancers
PremiumCompany AnnouncementsChimeric Therapeutics Reports Promising Results in CAR-T Cell Trial for GI Cancers
19d ago
CHM
Chimeric Therapeutics Secures $2.5M Advance to Boost Clinical Trials
Premium
Company Announcements
Chimeric Therapeutics Secures $2.5M Advance to Boost Clinical Trials
26d ago
CHM
Chimeric Therapeutics’ CHM CDH17 Receives FDA Fast Track Designation
Premium
Company Announcements
Chimeric Therapeutics’ CHM CDH17 Receives FDA Fast Track Designation
1M ago
CHM
Chimeric Therapeutics Lists New Securities on ASX
PremiumCompany Announcements
Chimeric Therapeutics Lists New Securities on ASX
1M ago
CHM
Chimeric Therapeutics Announces Change in Substantial Holder Interests
PremiumCompany Announcements
Chimeric Therapeutics Announces Change in Substantial Holder Interests
1M ago
CHM
Chimeric Therapeutics Expands Market Presence with New ASX Quotation
PremiumCompany Announcements
Chimeric Therapeutics Expands Market Presence with New ASX Quotation
1M ago
CHM
Chimeric Therapeutics Reports Promising Clinical Trial Results and Strengthened Financial Position
PremiumCompany Announcements
Chimeric Therapeutics Reports Promising Clinical Trial Results and Strengthened Financial Position
1M ago
CHM
Chimeric Therapeutics Announces $6.6 Million Placement Offer
PremiumCompany AnnouncementsChimeric Therapeutics Announces $6.6 Million Placement Offer
1M ago
CHM
Chimeric Therapeutics Highlights Risks in Clinical Trials
Premium
Company Announcements
Chimeric Therapeutics Highlights Risks in Clinical Trials
1M ago
CHM
Chimeric Therapeutics Advances CHM CDH17 Trial to Dose Level 2
Premium
Company Announcements
Chimeric Therapeutics Advances CHM CDH17 Trial to Dose Level 2
2M ago
CHM
Chimeric Therapeutics Announces $6.6 Million Capital Raising and Investor Webinar
PremiumCompany Announcements
Chimeric Therapeutics Announces $6.6 Million Capital Raising and Investor Webinar
2M ago
CHM
Chimeric Therapeutics Announces Proposed Securities Issue to Boost R&D
PremiumCompany Announcements
Chimeric Therapeutics Announces Proposed Securities Issue to Boost R&D
2M ago
CHM
Chimeric Therapeutics Announces Proposed Securities Issue to Bolster Capital
PremiumCompany Announcements
Chimeric Therapeutics Announces Proposed Securities Issue to Bolster Capital
2M ago
CHM
Chimeric Therapeutics Secures $6.6 Million to Boost Clinical Trials
PremiumCompany Announcements
Chimeric Therapeutics Secures $6.6 Million to Boost Clinical Trials
2M ago
CHM
Chimeric Therapeutics Initiates Trading Halt for Capital Raising Announcement
PremiumCompany AnnouncementsChimeric Therapeutics Initiates Trading Halt for Capital Raising Announcement
2M ago
CHM
Chimeric Therapeutics Reports Promising Results in ADVENT-AML Trial
Premium
Company Announcements
Chimeric Therapeutics Reports Promising Results in ADVENT-AML Trial
2M ago
CHM
Chimeric Therapeutics Initiates Trading Halt Ahead of Clinical Trial Data Release
Premium
Company Announcements
Chimeric Therapeutics Initiates Trading Halt Ahead of Clinical Trial Data Release
2M ago
CHM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >